In this week’s DeviceTalks Weekly Podcast, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of […]
Zoll Medical
Zoll Medical acquires Respicardia
Zoll Medical said today that it has acquired Respicardia and its neurostimulation tech for treating sleep apnea. The financial terms of the deal were not disclosed. Respicardia makes implantable neurostimulators to treat moderate to severe central sleep apnea (CSA). The system is FDA approved to treat severe CSA in adult patients with reduced cardiac function. […]
FDA says lay rescuers can use Zoll AED 3 defibrillator
Zoll Medical announced yesterday that its Zoll AED 3 defibrillator received FDA premarket approval (PMA) for use by lay rescuers. Chelmsford, Mass.-based Zoll’s AED 3 defibrillator uses CPR technology with integrated, real-time feedback to deliver guideline-compliant CPR to improve outcomes from sudden cardiac arrest. The company touts its enhanced technology as the first in the […]
Zoll Medical returns HHS funds meant to support health providers
Zoll Medical said today that it’s returning money that it automatically received from the U.S. Department of Health and Human Services’ $50 billion Cares Act Provider Relief Fund. “Although we meet all of the qualifications for the funds we received and could fully comply with the terms and conditions required to keep the funds, we […]
Zoll Medical hit with dozens of COVID-19 cases
Zoll Medical‘s Pawtucket, R.I. facility — which manufacturers parts for ventilators and defibrillators — has seen 75 cases of COVID-19, according to a report in The Providence Journal. Zoll learned of the outbreak in late March, sending all the plant workers home April 2–6 as it cleaned the facility and reoriented the workspace, Zoll Medical […]
Zoll Medical wins CE Mark for oxygen therapy system
Zoll Medical announced today that it received CE Mark approval in Europe for its TherOx SuperSaturated Oxygen (SSO2) therapy system. SSO2 therapy offers interventional cardiologists a treatment beyond percutaneous coronary intervention (PCI) that significantly reduces muscle damage in heart attack patients. Chelmsford, Mass.-based Zoll’s therapy system delivers hyperbaric levels of oxygen directly to damaged heart […]
Hamilton Medical, Vyaire lead the way among 7 new ventilator contracts from HHS
Hamilton Medical, Vyaire and Zoll Medical by far had the largest ventilator contracts among seven new deals that the U.S. Department of Health and Human Services has announced. The contracts, announced yesterday evening and worth a total of $1.44 billion, come on top of previously announced deals with Royal Philips (NYSE:PHG), which is receiving $646.7 million, […]
U.S. ventilator manufacturing is rapidly expanding: Here’s how
Amid a shortage of life-saving ventilators due to the coronavirus pandemic, medical device companies are rapidly expanding production, trade group AdvaMed reported today. Respiratory device companies that belong to AdvaMed have boosted ventilators production to 2,000–3,000 per week — and expect to soon reach 5,000–7,000 ventilators per week. Last year, the same companies were making […]
4 medtech companies ink $84m government ventilator contract
The U.S. Defense Logistics Agency (DLA) signed an $84.4 million contract over the weekend with four medtech companies to produce 8,000 ventilators to fight the COVID-19 pandemic. The contract is with Combat Medical Systems, Hamilton Medical, Vyaire Medical and Zoll Medical, according to the agency. Shipments may begin in a few days with time-phased delivery […]
Zoll Medical wins FDA nod for second-gen TherOx system
Zoll Medical Corp. announced today that it received FDA approval for its second-generation TherOx system for SuperSaturated Oxygen (SSO2) therapy in heart attack patients. The Chelmsford, Mass.–based company’s TherOx system is designed to deliver the SSO2 therapy that has been shown in clinical trials to reduce infarct size (heart muscle damage) in “widowmaker” heart attack […]
AdvaMed: Invoking Defense Production Act could hinder U.S. medtech imports
Forcing manufacturers to repurpose their production lines to make equipment to fight the coronavirus epidemic might actually hurt the U.S. supply of those items, the head of medtech trade group AdvaMed said today. AdvaMed officials have talked with U.S. secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn about medtech […]
